Predicting the Long-Term Effects of Cardiac Resynchronization Therapy on Mortality From Baseline Variables and the Early Response. A Report From the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial

Journal of the American College of Cardiology

Volumn 52, Issue 6, 2008, Pages 438-445

  Cleland, John ^a   Freemantle, Nick ^b   Ghio, Stefano ^c   Fruhwald, Friedrich ^d   Shankar, Aparna ^b   Marijanowski, Monique ^e   Verboven, Yves ^e   Tavazzi, Luigi ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

cardiac resynchronization therapy; heart failure; randomized controlled trial

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; BLOOD LEVEL; CARDIAC RESYNCHRONIZATION THERAPY; CHI SQUARE TEST; DISEASE MARKER; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART FAILURE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS;

EID: 47849118987     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.036     Document Type: Article

References (32)

1. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
2. Cleland J.G., Daubert J.C., Erdmann E., et al., CARE-HF Investigators. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27 (2006) 1928-1932
3. Cleland J.G., Daubert J.C., Erdmann E., et al., CARE-HF Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
4. Freemantle N., Tharmanathan P., Calvert M.J., Abraham W.T., Ghosh J., and Cleland J.G. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction: a systematic review and meta-analysis. Eur J Heart Fail 8 (2006) 433-440
5. Yu C.M., Abraham W.T., Bax J., et al., PROSPECT Investigators. Predictors of Response to Cardiac Resynchronization Therapy (PROSPECT)-study design. Am Heart J 149 (2006) 600-605
6. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
7. Yu C.M., Fung J.W., Zhang Q., et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 110 (2004) 66-73
8. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
9. Marcus G.M., Rose E., Voloria E.M., et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 46 (2005) 2208-2214
10. Cleland J.G., Abdellah A.T., Khaleva O., Coletta A.P., and Clark A.L. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. Eur J Heart Fail 9 (2007) 1070-1073
11. Bleeker G.B., Lamb T.A., Boersma E., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
12. Yu C.M., Bleeker G.B., Fung J.W., et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005) 1580-1586
13. Kubanek M., Malek I., Bytesnik J., et al. Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months. Eur J Heart Fail 8 (2006) 832-840
14. Cleland J.G., Daubert J.C., Erdmann E., et al. Baseline characteristics of patients recruited into the CARE-HF study. L. Eur J Heart Fail 7 (2005) 205-214
15. Cleland J.G., Daubert J.C., Erdmann E., et al., CARE-HF Study Steering Committee and Investigators. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 3 (2001) 481-489
16. Ghio S., Freemantle N., Serio A., et al. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study). Eur J Echocardiogr 7 (2006) 373-378
17. Bax J.J., Ansalone G., Breithardt O.-A., et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use?. A critical appraisal. J Am Coll Cardiol 44 (2004) 1-9
18. Molhoek S.G., Bax J.J., van Erven L., et al. Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 90 (2004) 97-98
19. Clark A.L., Goode K., and Cleland J.G. The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure. Eur J Heart Fail (2008) May 21;[E-pub ahead of print]
20. Chattopadhyay S., Alamgir F., Nikitin N.P., Fraser A.G., Clark A.L., and Cleland J.G. The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction. Eur J Heart Fail 10 (2008) 412-420
21. Lafitte S., Bordachar P., Lafitte M., et al. Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol 47 (2006) 2253-2259
22. de Silva R., Rigby A.S., Witte K.K.A., et al. Anemia, renal dysfunction and their interaction in patients with chronic heart failure. Am J Cardiol 98 (2006) 391-398
23. Fruhwald F.M., Fahrleitner-Pammer A., Berger R., et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28 (2007) 1592-1597
24. Ghio S., Freemantle N., Cleland J.G., et al., CARE-HF Investigators. Long-term ventricular reverse remodeling with cardiac resynchronization therapy. Results from the CARE-HF Trial (abstr). Circulation 112 (2005) II672
25. Cowburn P.J., Cleland J.G., Coats A.J.S., and Komajda M. Risk stratification in chronic heart failure. Eur Heart J 19 (1998) 696-710
26. Khan N.K., Goode K.M., Cleland J.G., et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 9 (2007) 491-501
27. Cleland J.G., Pennell D.J., Ray S., et al. The carvedilol hibernation reversible ischaemia trial: marker of success (CHRISTMAS). Eur J Heart Fail 1 (1999) 191-196
28. Hummel J.P., Lindner J.R., Belcik J.T., et al. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. Heart Rhythm 2 (2005) 1211-1217
29. Richardson M., Freemantle N., Calvert M.J., Cleland J.G., and Tavazzi L. Predictors and treatment response with cardiac resynchronisation therapy in patients with heart failure characterised by dyssynchrony: a predefined analysis from the CARE-HF trial. Eur Heart J 28 (2007) 1827-1834
30. Adamson P.B., St John Sutton M.G., Plappert T., Abraham W.T., Hilpisch K.E., and Hill M.S. Echo-defined ventricular dyssynchrony predicts magnitude of response to cardiac resynchronization (abstr). J Cardiac Fail 8 Suppl (2002) S50
31. Leon A.R., Abraham W.T., Brozena S., et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol 46 (2006) 2298-2304
32. Wu A.H., Aaronson K.D., Bolling S.F., Pagani F.D., Welch K., and Koelling T.M. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387